“…Since the diagnosis of autism is challenging and no biomarker is available [ 51 ], the development of computational models based on early abnormalities such as the differences in gaze processing might be of substantial help to improve and anticipate the diagnosis, thus, making it possible to initiate treatment at an earlier stage, when it is most effective [ 52 ]. Eye tracking measurements that might prove to be useful as early biomarkers include dysregulations in pupil dilation [ 53 , 54 , 55 ], changes in saccadic behavior, differences in gaze patterns during vision exposure to social stimuli [ 56 , 57 , 58 ] and analysis of scan paths or gaze patterns [ 59 , 60 , 61 , 62 , 63 , 64 ]. Some studies combined eye tracking data with other measurements such as resting-state EEG data [ 65 , 66 , 67 ].…”